New COVID vaccines, treatments: Feds begin doling out portion of $5 billion for future care
The money will be split by small biotech companies that might struggle to pay for clinical trials comparing new vaccines against those now available.
The money will be split by small biotech companies that might struggle to pay for clinical trials comparing new vaccines against those now available.